Opportunity Information: Apply for PA 18 621
The funding opportunity titled "Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp Clinical Trial Optional)" (PA 18-621) is a National Institutes of Health (NIH) program administered through the National Institute of Mental Health (NIMH). It is designed specifically to provide administrative supplement funding to organizations that already hold active NIMH grants. Rather than supporting entirely new, standalone projects, this mechanism is meant to extend or enhance existing NIMH-funded work in ways that directly address mental health disparities in the United States. The overarching emphasis is on disparities tied to race and ethnicity, geographic location, and socioeconomic status, with the goal of producing actionable research that helps reduce and ultimately eliminate unequal mental health outcomes and unequal access to effective care.
The core purpose of the supplement is to stimulate research that fits within the scientific scope of the parent NIMH award while sharpening the project focus on disparities. This can include studies that identify mechanisms underlying disparities or differences in mental health status across groups, such as social determinants, structural and contextual factors, and barriers that shape risk, diagnosis, treatment engagement, retention, and outcomes. It can also include work that improves the delivery of mental health interventions among diverse populations, which may involve adapting evidence-based practices, testing strategies to improve implementation in real-world settings, or strengthening methods for reaching underserved or marginalized communities. The "clinical trial optional" language indicates that proposed supplement activities may include clinical trial elements if appropriate, but a clinical trial is not required.
This opportunity falls under the grant funding instrument category and the health funding activity category, with CFDA number 93.242. A wide range of applicants are listed as eligible, reflecting NIMH's interest in supporting disparity-focused research across many types of institutions and community contexts. Eligible applicants include state, county, city or township governments, special district governments, and independent school districts, as well as public and state-controlled institutions of higher education and private institutions of higher education. Tribal entities are included, such as federally recognized Native American tribal governments and tribal organizations that are not federally recognized. Additional eligible organizational types include public housing authorities or Indian housing authorities, nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education), for-profit organizations other than small businesses, and small businesses. The listing also explicitly highlights certain community-anchored and minority-serving institutions and organizations as eligible, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
At the same time, there are clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. In practice, that means the funded supplement activities must be carried out within allowable U.S.-based organizational structures and settings, consistent with NIH policy and the FOA's eligibility constraints.
The FOA was created on February 1, 2018, and the listed original closing date is June 1, 2020. While those dates describe the posting and an original deadline, anyone considering this opportunity in the present should confirm the current status, availability, and any successor announcements or updated deadlines through NIH/NIMH sources, since NIH funding opportunities are sometimes reissued, modified, or closed over time.
In summary, PA 18-621 is best understood as a targeted add-on funding mechanism for current NIMH awardees who can meaningfully extend their ongoing research to address U.S. mental health disparities. It encourages projects that either explain why disparities exist (mechanisms and contributing factors) or improve how mental health interventions are delivered, accessed, and sustained in diverse and underserved populations, while keeping the work aligned with the aims and scope of the existing NIMH-funded parent grant.Apply for PA 18 621
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2018-02-01.
- Applicants must submit their applications by 2020-06-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the title of this funding opportunity?
The funding opportunity is titled "Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp Clinical Trial Optional)" (PA 18-621).
2) Which agency and NIH institute administer this opportunity?
This is a National Institutes of Health (NIH) opportunity administered through the National Institute of Mental Health (NIMH).
3) What type of funding mechanism is this?
This opportunity provides administrative supplement funding. It is intended to add funds to an existing, active NIMH award rather than support a new, standalone grant project.
4) Who is this opportunity designed for?
It is designed specifically for organizations that already hold active NIMH grants and want to extend or enhance that existing NIMH-funded work to directly address mental health disparities in the United States.
5) Can an organization apply if it does not currently have an active NIMH award?
No. Based on the description provided, this administrative supplement is specifically for organizations that already hold active NIMH grants.
6) What is the overall goal of the supplement?
The goal is to produce actionable research that helps reduce and ultimately eliminate unequal mental health outcomes and unequal access to effective care in the United States.
7) What kinds of disparities are emphasized?
The emphasis is on mental health disparities tied to race and ethnicity, geographic location, and socioeconomic status.
8) Does the proposed supplement work need to align with the parent award?
Yes. The supplement is meant to stimulate research that fits within the scientific scope of the parent NIMH award while sharpening the project focus on mental health disparities.
9) What types of research activities are encouraged?
Encouraged activities include (1) studies that identify mechanisms underlying disparities or differences in mental health status across groups, and (2) work that improves the delivery of mental health interventions among diverse and underserved populations.
10) What does "mechanisms underlying disparities" mean in this context?
It refers to research that examines factors contributing to disparities, such as social determinants, structural and contextual factors, and barriers that shape risk, diagnosis, treatment engagement, retention, and outcomes.
11) What does "improving the delivery of mental health interventions" include?
It can include adapting evidence-based practices, testing strategies to improve implementation in real-world settings, or strengthening methods for reaching underserved or marginalized communities.
12) Are clinical trials required under this opportunity?
No. The "clinical trial optional" designation means supplement activities may include clinical trial elements if appropriate, but a clinical trial is not required.
13) Are clinical trials allowed under this opportunity?
Yes. Clinical trial elements may be included if appropriate for the proposed supplement work, consistent with the "clinical trial optional" description.
14) What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.242.
15) What general funding categories are referenced?
This opportunity falls under the grant funding instrument category and the health funding activity category.
16) Which types of U.S. government entities are listed as eligible applicants?
Eligible applicants include state governments, county governments, city or township governments, special district governments, and independent school districts.
17) Are colleges and universities eligible?
Yes. Eligible applicants include public and state-controlled institutions of higher education as well as private institutions of higher education.
18) Are Tribal entities eligible?
Yes. Eligibility includes federally recognized Native American tribal governments and tribal organizations that are not federally recognized.
19) Are nonprofits eligible to apply?
Yes. Nonprofit organizations with or without 501(c)(3) status are listed as eligible, as long as they are not institutions of higher education.
20) Are for-profit organizations eligible?
Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also listed as eligible.
21) Are public housing authorities eligible?
Yes. Public housing authorities and Indian housing authorities are listed as eligible applicants.
22) Are minority-serving institutions specifically included in the eligibility list?
Yes. The eligibility listing explicitly highlights a range of minority-serving institutions and community-anchored organizations as eligible.
23) Which minority-serving institutions are explicitly mentioned?
The listing includes Alaska Native and Native Hawaiian Serving Institutions, Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
24) Are faith-based and community-based organizations included?
Yes. Faith-based or community-based organizations are explicitly highlighted as eligible.
25) Are regional organizations and U.S. territories included?
Yes. Regional organizations, eligible federal agencies, and U.S. territories or possessions are listed among eligible applicants.
26) Are non-U.S. (foreign) organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply under this opportunity.
27) Can a U.S. organization include a non-domestic component in this supplement?
No. Non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed.
28) Where must the funded supplement activities take place?
In practice, the supplement activities must be carried out within allowable U.S.-based organizational structures and settings, consistent with NIH policy and the FOA's eligibility constraints.
29) When was this FOA created, and what is the listed original closing date?
The FOA was created on February 1, 2018, and the listed original closing date is June 1, 2020.
30) Is this opportunity necessarily still open today?
Not necessarily. The provided information notes the original dates and advises applicants to confirm the current status, availability, and any successor announcements or updated deadlines through NIH/NIMH sources.
31) What is the main takeaway about PA 18-621?
PA 18-621 is best understood as a targeted add-on funding mechanism for current NIMH awardees who can extend ongoing NIMH-funded research to address U.S. mental health disparities, either by explaining why disparities exist or by improving access, delivery, and sustained impact of effective interventions in diverse and underserved populations.
Browse more opportunities from the same category: Health
Next opportunity: NIAMS Skin Biology and Diseases Resource-based Centers (P30)
Previous opportunity: Behavioral and Integrative Treatment Development Program (R03 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 621
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 621) also looked into and applied for these:
| Funding Opportunity |
|---|
| Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional) Apply for PA 18 620 Funding Number: PA 18 620 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 - Clinical Trial Optional) Apply for PA 18 619 Funding Number: PA 18 619 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required) Apply for RFA AG 18 030 Funding Number: RFA AG 18 030 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) Apply for PA 18 631 Funding Number: PA 18 631 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 19 130 Funding Number: RFA MH 19 130 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 633 Funding Number: PAR 18 633 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects' Research (R15 Clinical Trial Optional) Apply for PA 18 635 Funding Number: PA 18 635 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Apply for PAR 18 632 Funding Number: PAR 18 632 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Apply for PAR 18 630 Funding Number: PAR 18 630 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) Apply for PAR 18 628 Funding Number: PAR 18 628 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1 Clinical Trial Not Allowed) Apply for RFA AI 18 001 Funding Number: RFA AI 18 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed) Apply for RFA NS 18 015 Funding Number: RFA NS 18 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional) Apply for PA 18 642 Funding Number: PA 18 642 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional) Apply for PAR 18 643 Funding Number: PAR 18 643 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIAMS Musculoskeletal Biology and Medicine Resource-based Centers (P30 Clinical Trial Not Allowed) Apply for RFA AR 19 002 Funding Number: RFA AR 19 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIAMS Skin Biology and Diseases Resource-based Centers (P30) Apply for RFA AR 19 001 Funding Number: RFA AR 19 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed) Apply for RFA NS 18 024 Funding Number: RFA NS 18 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp Clinical Trial Optional) Apply for PA 18 647 Funding Number: PA 18 647 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional) Apply for PA 18 653 Funding Number: PA 18 653 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 18 656 Funding Number: PAR 18 656 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 621", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.